Vonoprazan Fumarate

CAS 1260141-27-2 25 API suppliersSmall Molecule

Overview

Vonoprazan Fumarate is a potassium-competitive acid blocker (PCAB) used to treat conditions such as gastroesophageal reflux disease (GERD). It provides an alternative mechanism of action to proton pump inhibitors by inhibiting the gastric H+, K+-ATPase enzyme.

API suppliers (25)

Suppliers of Vonoprazan Fumarate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India13China7Pakistan1

Country recorded for 21 of 25 suppliers.

10 of 25 hold a GMP certificate on record in the EU or UK registers

Therapeutic areas

Gastroenterology
Verified Supplier Partner

Do you supply Vonoprazan Fumarate? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.